title: Cost-effective, evidence-based infertility care.
abstract: Economic evaluation of health care interventions is becoming increasingly important as the demand for services increases. For unexplained infertility, in-vitro fertilization is not a cost-effective first-line treatment option compared with ovarian stimulation and intrauterine insemination. In clomiphene citrate-resistant polycystic ovarian syndrome, in-vitro fertilization may be cost-effective.
authors.affiliation: Department of Obstetrics and Gynaecology, McMaster University, Hamilton, Ontario, Canada. dayas@fhs.csu.mcmaster.ca
authors.forename: S
authors.initials: S
authors.lastname: Daya
mesh_terms: D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine / Q000191:economics*; D005260:Female; D005307:Fertilization in Vitro / Q000191:economics*; D006801:Humans; D007247:Infertility, Female / Q000628:therapy*